WO2007007183A3 - Compositions of antiviral compound - Google Patents
Compositions of antiviral compound Download PDFInfo
- Publication number
- WO2007007183A3 WO2007007183A3 PCT/IB2006/001952 IB2006001952W WO2007007183A3 WO 2007007183 A3 WO2007007183 A3 WO 2007007183A3 IB 2006001952 W IB2006001952 W IB 2006001952W WO 2007007183 A3 WO2007007183 A3 WO 2007007183A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ribavirin
- compositions
- antiviral compound
- free flowing
- agglomerating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
Abstract
An oral pharmaceutical composition comprising free flowing ribavirin and one or more pharmaceutically acceptable excipients, wherein the free flowing ribavirin is prepared by agglomerating the non-free flowing ribavirin using a solvent or by controlling the crystallization during synthesis of ribavirin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06765637A EP1904071A2 (en) | 2005-07-08 | 2006-07-05 | Compositions of antiviral compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN906/CHE/2005 | 2005-07-08 | ||
IN906CH2005 | 2005-07-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007007183A2 WO2007007183A2 (en) | 2007-01-18 |
WO2007007183A3 true WO2007007183A3 (en) | 2007-08-23 |
Family
ID=37564409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/001952 WO2007007183A2 (en) | 2005-07-08 | 2006-07-05 | Compositions of antiviral compound |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1904071A2 (en) |
WO (1) | WO2007007183A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1281715A1 (en) * | 2001-07-30 | 2003-02-05 | Clariant Life Science Molecules (Italia) SpA | Process for the preparation of ribavirin |
US20040258751A1 (en) * | 2002-09-19 | 2004-12-23 | Kerrish Donald J. | Composition containing ribavirin and use thereof |
EP1455801B1 (en) * | 2001-12-21 | 2005-03-09 | Biopartners GmbH | Ribavirin granulate for producing coated tablets |
-
2006
- 2006-07-05 EP EP06765637A patent/EP1904071A2/en not_active Withdrawn
- 2006-07-05 WO PCT/IB2006/001952 patent/WO2007007183A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1281715A1 (en) * | 2001-07-30 | 2003-02-05 | Clariant Life Science Molecules (Italia) SpA | Process for the preparation of ribavirin |
EP1455801B1 (en) * | 2001-12-21 | 2005-03-09 | Biopartners GmbH | Ribavirin granulate for producing coated tablets |
US20040258751A1 (en) * | 2002-09-19 | 2004-12-23 | Kerrish Donald J. | Composition containing ribavirin and use thereof |
Non-Patent Citations (1)
Title |
---|
TONG H H Y ET AL: "An improved thermoanalytical approach to quantifying trace levels of polymorphic impurity in drug powders", INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, NL, vol. 295, no. 1-2, 13 May 2005 (2005-05-13), pages 191 - 199, XP004852854, ISSN: 0378-5173 * |
Also Published As
Publication number | Publication date |
---|---|
EP1904071A2 (en) | 2008-04-02 |
WO2007007183A2 (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007148185A3 (en) | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors | |
MY155402A (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
WO2006049835A3 (en) | Indole and benzimidazole derivatives | |
WO2008049116A3 (en) | Substituted indoles | |
AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
WO2007096151A3 (en) | Inhibitors of p38-kinase for treatment of pulmonary hypertension | |
WO2006046030A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
WO2007099548A3 (en) | Novel 11 beta - hydroxyandrosta-4-ene-3-ones | |
WO2008142055A3 (en) | Antiviral agents | |
TW200744588A (en) | Pharmaceutical composition for external use | |
WO2005115470A3 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING β-CARBOLINE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER | |
WO2008092954A8 (en) | Polymorphic forms of a macrocyclic inhibitor of hcv | |
WO2008012622A3 (en) | Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor | |
WO2007014054A3 (en) | Benzenesulfonamide inhibitor of ccr2 chemokine receptor | |
WO2008044243A3 (en) | Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof | |
WO2007090882A3 (en) | Pharmaceutical extended release compositions comprising pramipexole | |
WO2009051119A1 (en) | Pyrimidyl indoline compound | |
WO2005117895A3 (en) | Compositions comprising meloxicam | |
WO2008008718A3 (en) | Cyclopentane derivatives as antiglaucoma agents | |
WO2006042954A8 (en) | 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof | |
WO2007017728A3 (en) | Novel heterocyclic compounds | |
WO2008072053A3 (en) | Substituted arylpyrazoles | |
WO2006077024A3 (en) | 5-aminoindole derivatives | |
WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2006765637 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06765637 Country of ref document: EP Kind code of ref document: A2 |
|
WWP | Wipo information: published in national office |
Ref document number: 2006765637 Country of ref document: EP |